GlaxoSmithKline Stock Forecast, Price & News

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. There are currently 2 sell ratings, 5 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" GlaxoSmithKline stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares.
View analyst ratings for GlaxoSmithKline or view top-rated stocks.

Wall Street analysts have given GlaxoSmithKline a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but GlaxoSmithKline wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

GlaxoSmithKline saw a drop in short interest in June. As of June 30th, there was short interest totaling 14,450,000 shares, a drop of 22.4% from the June 15th total of 18,630,000 shares. Based on an average trading volume of 4,580,000 shares, the days-to-cover ratio is currently 3.2 days. Currently, 0.6% of the shares of the company are short sold.
View GlaxoSmithKline's Short Interest.

GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.
View our earnings forecast for GlaxoSmithKline.

GlaxoSmithKline plc (NYSE:GSK) announced its earnings results on Tuesday, February, 2nd. The pharmaceutical company reported $0.62 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.64 by $0.02. The pharmaceutical company earned $8.74 billion during the quarter, compared to analysts' expectations of $8.71 billion. GlaxoSmithKline had a net margin of 16.01% and a trailing twelve-month return on equity of 24.57%. The firm's revenue for the quarter was down 1.8% on a year-over-year basis. During the same period last year, the business posted $0.39 earnings per share.
View GlaxoSmithKline's earnings history.

GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GSK shares have increased by 0.4% and is now trading at $40.03.
View which stocks have been most impacted by COVID-19.

GlaxoSmithKline announced a quarterly dividend on Wednesday, May 5th. Stockholders of record on Friday, May 21st will be given a dividend of $0.6367 per share on Thursday, July 8th. This represents a $2.55 annualized dividend and a dividend yield of 6.36%. The ex-dividend date is Thursday, May 20th. This is a boost from GlaxoSmithKline's previous quarterly dividend of $0.63.
View GlaxoSmithKline's dividend history.

GlaxoSmithKline pays an annual dividend of $2.07 per share and currently has a dividend yield of 5.24%. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of GlaxoSmithKline is 69.46%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 69.23% next year. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend.
View GlaxoSmithKline's dividend history.

Some companies that are related to GlaxoSmithKline include Roche (RHHBY), Pfizer (PFE), Eli Lilly and (LLY), Novo Nordisk A/S (NVO), Abbott Laboratories (ABT), Novartis (NVS), AbbVie (ABBV), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), AstraZeneca (AZN), Sanofi (SNY), CSL (CSLLY), Zoetis (ZTS), Regeneron Pharmaceuticals (REGN) and Bayer Aktiengesellschaft (BAYRY).
View all of GSK's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), The Walt Disney (DIS) and NVIDIA (NVDA).

GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK."

GlaxoSmithKline's stock is owned by a variety of retail and institutional investors. Top institutional investors include Welch & Forbes LLC (0.02%), Clean Yield Group (0.01%), Usca Ria LLC (0.01%), Signature Wealth Management Group (0.00%), Old Port Advisors (0.00%) and Hohimer Wealth Management LLC (0.00%).
View institutional ownership trends for GlaxoSmithKline.

GSK stock was sold by a variety of institutional investors in the last quarter, including Hoertkorn Richard Charles, Raymond James Trust N.A., Kovack Advisors Inc., Red Door Wealth Management LLC, Capital Investment Advisory Services LLC, Mayflower Financial Advisors LLC, Signature Wealth Management Group, and Cozad Asset Management Inc..
View insider buying and selling activity for GlaxoSmithKline or view top insider-selling stocks.

GSK stock was acquired by a variety of institutional investors in the last quarter, including Brookstone Capital Management, Cardinal Capital Management, Clean Yield Group, Integrated Investment Consultants LLC, Usca Ria LLC, Meridian Wealth Management LLC, Hohimer Wealth Management LLC, and Sequoia Financial Advisors LLC.
View insider buying and selling activity for GlaxoSmithKline or or view top insider-buying stocks.

Shares of GSK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of GSK stock can currently be purchased for approximately $40.03.

GlaxoSmithKline has a market capitalization of $107.78 billion and generates $43.79 billion in revenue each year. The pharmaceutical company earns $7.38 billion in net income (profit) each year or $2.98 on an earnings per share basis.

GlaxoSmithKline employs 94,066 workers across the globe.

GlaxoSmithKline was founded in 2000.

The official website for GlaxoSmithKline is www.gsk.com.

GlaxoSmithKline is headquartered at 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS.

GlaxoSmithKline's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. The pharmaceutical company can be reached via phone at 442080475000 or via email at [email protected]